 |
Vision
strategy aims to tackle sight loss 'time bomb' |
| |
A landmark five-year strategy to improve the
eye-care of Scots has been launched in Holyrood (RNIB, UK) |
| |
|
|
Guidelines
for the Management of Diabetic Retinopathy |
| |
The objective of these guidelines is to assist
practitioners in making decisions about the appropriate health
care of patients with diabetes. 183-page PDF (NHMRC, Australia) |
| |
|
|
Less
talk, more action to tackle Scotland's soaring obesity epidemic |
| |
In advance of a debate on obesity in the Scottish
Parliament today (Thursday 4 September), BMA Scotland called on
politicians to take tough action to tackle childhood obesity (BMA,
Scotland, UK) |
| |
|
|
Point-of-care
testing (POCT) as a tool for screening for diabetes and pre-diabetes |
| |
POCT significantly underestimated the true blood
glucose at diagnostic levels for diabetes. POCT cannot be recommended
as a means of screening for or diagnosing diabetes or pre-diabetes
(Diabetic Medicine) |
| |
|
|
Patient
Safety in Diabetes Care and Intensive Glycemic Therapy |
| |
The two trials, ADVANCE and ACCORD, are clearly
landmark trials, both because of the high quality of the studies,
and the importance of the results. Yet, the two show what appears
to be conflicting conclusions (American Association of Clinical
Endocrinologists) |
| |
|
|
Addressing
insulin resistance in Type 1 diabetes |
| |
This review examines the evidence for insulin
resistance in the pathophysiology of Type 1 diabetes and its complications,
the problems associated with its measurement, and summarizes the
trials aimed at reducing insulin resistance in Type 1 diabetes
(Diabetic Medicine) |
| |
|
|
Insulin
detemir is characterized by a more reproducible pharmacokinetic
profile than insulin glargine in children and adolescents with
type 1 diabetes |
| |
The results from a randomized, double-blind,
controlled trial (Pediatric Diabetes) |
| |
|
|
Generex
Biotechnology to Sponsor International Diabetes Symposium in
Rome |
| |
Generex Biotechnology Corporation the leader
in drug delivery for metabolic diseases through the inner lining
of the mouth, will sponsor an international diabetes symposium
in Rome, Italy as an adjunct to the 44th Annual Meeting of the
European Association for the Study of Diabetes taking place in
Rome from September 6-11, 2008 (Market Watch) |
| |
|
|
Recent
additions to the Diabetes Specialist Library |
| |
What's New from the Diabetes Specialist Library
(NDST, UK) |
| |
|
